ClinicalTrials.gg
Not yet recruitingNCT07201090Updated Oct 1, 2025

Effects and Implementation of a Brief Version of Parent-Child Interaction Therapy

An interventional study of Brief Parent-Child Interaction Therapy with videos and virtual reality (360-degree VR)-films in Conduct Disorders in Children, Disruptive Behavior and Oppositional Defiant Disorder, sponsored by Karolinska Institutet. Not yet recruiting at 2 sites in Sweden. Open to participants aged 2 Years to 7 Years. Per ClinicalTrials.gov, last updated 2025-10-01.

Sponsored by Karolinska Institutet · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
15
Allocation
Not applicable
Ages
2 Years to 7 Years
Sex
All
01

Study summary

The aim of this study is to evaluate the effects and feasibility of a shortened version of Parent-Child Interaction Therapy (PCIT), supplemented with video vignettes of parenting skills and 360-virtual reality (VR)-films for parents of children aged 2-7 years with disruptive behavior problems. The main questions the study aims to answer, using a Single-Case Experimental Design, are:

  1. How feasible and acceptable is the implementation of brief PCIT-VR in Sweden?
  2. What are the preliminary effects of brief PCIT-VR?
  3. How do parents and clinicians experience brief PCIT-VR?

Families at child and adolescent psychiatry clinics will receive up to 10 PCIT sessions. Caregivers complete quantitative assessments before, during, after treatment, and at 6-months follow-up, and are asked to participate in interviews after PCIT. Feasibility and acceptability of brief PCIT VR is evaluated, as well as effectiveness outcomes, including changes in child disruptive behavior and parenting skills. Within-group analyses will examine trends in outcome measures over time.

Read the detailed description

BACKGROUND:

Persistent and clinically significant behavior problems are associated with long-term negative outcomes if left untreated. Early and effective interventions are critical for children's development and to reduce long-term societal costs.

Parent training programs are the most effective evidence-based interventions for children under 12 years with externalizing behavior problems. Parent-Child Interaction Therapy (PCIT) is one of the most rigorously evaluated programs for children aged 2-7 years. PCIT is distinctive in that it uses live coaching, where the therapist guides parents in real time as they interact with their child. Several meta-analyses demonstrate large effects of PCIT in reducing child disruptive behavior and improving parenting skills.

However, both the length of PCIT treatment and dropout rates remain challenges. The PCIT protocol often requires 15-25 sessions, and high attrition rates have been reported in routine care. Promisingly, research suggests that PCIT can still be effective when families end treatment early or when time-limited PCIT protocols are used. Further evaluations are needed to understand how effectiveness in briefer treatment formats can be maintained.

Using films and videos for parenting skills modelling, and virtual reality (VR) for practice may enhance skill learning and allow parents to continue practicing outside therapy sessions. VR can provide realistic training opportunities, enabling parents to observe and rehearse parenting skills. A study in the Netherlands has used VR in PCIT with promising results.

This study will implement and evaluate a time-limited (shortened) PCIT format combined with VR and film-based components (brief PCIT-VR). By limiting treatment to 10 sessions and supplementing with these pedagogical tools, the intervention aims to balance effectiveness with feasibility.

PURPOSE AND RESEARCH QUESTIONS:

This study will evaluate preliminary effects, aspects of feasibility, and experiences with brief PCIT-VR.

Research questions:

  1. How feasible and acceptable is the implementation of brief PCIT-VR in Sweden?
  2. What are the preliminary effects of brief PCIT-VR?
  3. How do parents and clinicians experience brief PCIT-VR?

METHOD:

This study will use a Single-Case Experimental Design (SCED).

Participants will be families including parents of children aged 2-7 years who present with disruptive behavior problems according to >114 on the Eyberg Child Behavior Inventory (ECBI). Families will be recruited through child and adolescent psychiatry clinics in Sweden. Clinicians working at these clinics will provide initial information about the study orally and in writing. Parents who express interest will be directed to an online portal where they receive written information. Both legal guardians provide written informed consent before participation. Parents fill out the ECBI to inform whether they meet inclusion criteria. A person from the research group contacts the family to provide more information and inform about inclusion or exclusion. If families are included, they are provided with login to a platform where they respond to weekly measurements, baseline/post treatment measurements, and during the treatment phase have access to video vignettes illustrating parenting skills. Parents will also have access to brief virtual reality-films at the clinic together with the therapist during two PCIT-sessions.

The study consists of three main phases: baseline, treatment, and follow-up. During the baseline phase (before treatment starts during approximately three weeks) and during the treatment phase, parents complete weekly questionnaires. In the middle of the treatment, parents respond to a longer measurement (ECBI). Before and after treatment, a larger battery of questions are administered (pre-, post- treatment, and 6-month follow-up assessments).

Each week during PCIT, parents are given access to a new module in the online platform with video vignettes of parenting skills, supplementing the session. The treatment phase involves up to 10 PCIT sessions. Semi-structured qualitative interviews will be conducted with both parents and clinicians after treatment to explore experiences, feasibility, and acceptability.

SAMPLE SIZE CALCULATION:

We aim to include a target of 15 families (approximately 15-30 parents), in line with SCED-study standards and similar SCED studies conducted internationally.

ANALYSES:

Quantitative data will be analyzed using visual inspection of weekly SCED graphs and statistical methods such as percent change calculations, Reliable Change Index analyses, and repeated-measures analyses of variance (ANOVA). Benchmarking will be used to compare outcomes with those from longer PCIT trials reported in the literature. Qualitative interview data will be analyzed thematically to identify key themes regarding feasibility, acceptability, and barriers and facilitators to implementation.

02

Conditions studied

  • Conduct Disorders in Children
  • Disruptive Behavior
  • Oppositional Defiant Disorder

Keywords

  • Parent training
  • Parent-Child Interaction Therapy
  • Virtual reality
03

In context

Problem Behavior

178 studies on the registry are indexed under Problem Behavior; 47 are open to participants now.

This study's planned enrollment of 15 is below the median of 90 across 165 interventional studies indexed under Problem Behavior.

Browse Problem Behavior studies →

Lead sponsor

Karolinska Institutet is the lead sponsor of 1,148 studies on the registry; 276 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
2 Years to 7 Years
Sexes eligible
All
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Child aged 2-7 years
  • Elevated disruptive behavior (ECBI score >114)
  • Parent speaks Swedish or English

Exclusion criteria

Exclusion Criteria:

  • Child or family requiring more urgent intervention
  • Parent condition that prevents VR use (e.g., epilepsy, severe migraine, adverse VR experiences)
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
15 participants (estimated)

Study arms

  • Experimental
    Brief Parent-Child Interaction Therapy with videos and virtual reality (360-degree VR)-films

    10 sessions of Parent-Child Interaction Therapy (PCIT), supplemented with brief role-modeling videos of parenting skills, provided through an online project platform, and virtual reality (360-degree VR)-films shown during treatment sessions.

    Behavioral: Brief Parent-Child Interaction Therapy with videos and virtual reality (360-degree VR)-films

Interventions

  • BehavioralBrief Parent-Child Interaction Therapy with videos and virtual reality (360-degree VR)-films

    10 sessions of PCIT delivered by trained psychologists, supplemented with videos and 360-degree VR-films Sessions follow the standard PCIT structure, with an initial phase focused on child-directed interaction, followed by a second, modified phase, focused on parent-directed interaction. To support skill learning, families are provided with digital materials including conventional video modules at home and 360-degree virtual reality (VR) films. The VR films are shown during two sessions at the clinic. Additional videos are available online through a platform for parents to view and practice between sessions. These tools allow parents to rehearse skills flexibly in their home environment and reinforce the in-session training.

    Also known as: Brief PCIT-VR

06

What researchers measure

Primary outcomes

  1. Mean change from screening in parent-ratings of child behavior problems on the Eyberg Child Behavior Inventory (ECBI) - Intensity scale

    Measures frequency of externalizing behaviors in children. The scale includes 36 items which are rated on a 7-point-scale (1 to 7). The total scale sum ranges from minimum 36 to a maximum sum of 252. Higher score indicates more disruptive behavior problems.

    Time frame: Screening (at inclusion), pre-treatment (treatment phase week 0), mid treatment (treatment phase week 6), post-treatment (treatment phase week 10), and at 6-months follow-up (6 months from pre-treatment assessment)

  2. Mean change from screening in parent-ratings of child behavior problems on the Eyberg Child Behavior Inventory - Problem scale

    Measures externalizing behaviors in children. The scale includes 36 items which are rated yes/no (1-0), indicating whether the behavior is experienced as problematic. Minimum summary score is 0, maximum score is 36. Higher score indicates more disruptive behavior problems.

    Time frame: Screening (at inclusion), pre-treatment (treatment phase week 0), mid treatment (treatment phase week 6), post-treatment (treatment phase week 10), and at 6-months follow-up (6 months from pre-treatment assessment)

  3. Change from baseline phase to treatment phase in weekly reported disruptive behavior

    Three weekly questions on disruptive behavior rated on an 8 point scale from 0-7. Minimum summary score is 0, maximum score is 21. Higher score indicates more disruptive behaviors.

    Time frame: Weekly throughout baseline phase (baseline phase week 1-4) and treatment phase (treatment phase week 1-10).

Secondary outcomes

  1. Mean change from pre-treatment in parent-rated callous unemotional behaviors on the Inventory of Callous Unemotional traits (ICU) scale

    The 12 item version of the Inventory of Callous Unemotional scale measures perceived callous or unemotional behaviors. The scale consists of 12 items rated on a 4-point Likert scale from 0 to 3. Total scores range from 0 to 36, with higher scores indicating higher levels.

    Time frame: Pre-treatment (treatment phase week 0), post-treatment (treatment phase week 10)

  2. Mean change from pre-treatment in parent-rated stress on the Perceived Stress Scale (PSS)

    The 10 item Perceived Stress Scale measures perceived stress on a 5-point Likert scale scored 0-4 (minimum scale value is 0, maximum is 40). Higher scores indicate more stress.

    Time frame: Pre-treatment (treatment phase week 0), post-treatment (treatment phase week 10), and at 6-months follow-up (6 months from pre-treatment assessment)

  3. Mean change from pre-treatment in parent-rated parenting behaviors on the Parenting Young Children (PARYC) - frequency scale

    A 21 item rating scale completed by parents, measuring parenting behaviors and strategies. Parents rate the frequency of parenting strategies/activities on a scale scored 1-5 (ranging between 21-105). Higher values represent using positive parenting strategies more frequently.

    Time frame: Pre-treatment (treatment phase week 0), post-treatment (treatment phase week 10), and at 6-months follow-up (6 months from pre-treatment assessment)

  4. Mean change from pre-treatment in parent-rated parenting behaviors on the Parenting Young Children (PARYC) - problem scale

    A 21 item rating scale completed by parents, measuring parenting behaviors and strategies. Parents indicate whether they find performing the parenting strategy/activity problematic (yes/no; rated 1-0), with a summary score ranging between 0-21. Higher values reflect greater parenting challenges.

    Time frame: Pre-treatment (treatment phase week 0), post-treatment (treatment phase week 10), and at 6-months follow-up (6 months from pre-treatment assessment)

  5. Change from baseline phase to treatment phase in weekly reported warmth and relationship quality

    Four weekly questions on warmth and relationship-enhancing behaviors (playing, doing nice things, positive attention and affection). Rated on a 7 point scale from 0-6. Minimum summary score is 0, maximum summary score is 24. Higher scores indicate higher levels of warmth and relationship-enhancing behaviors.

    Time frame: Weekly throughout baseline phase (baseline phase week 1-4) and treatment phase (treatment phase week 1-10).

  6. Change from baseline phase to treatment phase in weekly reported parental anger

    One weekly question of whether parents have felt upset with or angry at their children. Rated on a 7 point scale from 0-6. Higher score indicates more frequent experiences of anger.

    Time frame: Weekly throughout baseline phase (baseline phase week 1-4) and treatment phase (treatment phase week 1-10).

  7. Change from baseline phase to treatment phase in weekly reported emotion regulation

    If parents report being angry at least once across the past week, two follow-up questions inquire about how parents handled the situation. These items are rated on a 6 point scale scored 0-5. Summary score ranges between 0 and 10. Higher scores indicate more frequent instances of remaining calm.

    Time frame: Weekly throughout baseline phase (baseline phase week 1-4) and treatment phase (treatment phase week 1-10).

  8. Change from baseline phase to treatment phase in weekly reported consistent parenting

    One item assesses whether parents have been consistent with holding on to rules despite repeated requests from their children. Responses are rated on a 6 point scale (0-5), with higher scores indicating greater consistency.

    Time frame: Weekly throughout baseline phase (baseline phase week 1-4) and treatment phase (treatment phase week 1-10).

  9. Mean change from baseline in parental emotion regulation on the Parent Emotion Regulation Scale

    Parental emotion regulation will be measured with the Parent Emotion Regulation Scale. The 20 items are scored on a 5-point scale (1 to 5). A total summary score ranges between 20 and 100, where a higher score indicates better regulation of emotions.

    Time frame: Pre-treatment (treatment phase week 0), post-treatment (treatment phase week 10), and at 6-months follow-up (6 months from pre-treatment assessment)

Other outcomes

  1. Post treatment satisfaction on the Therapy Attitude Inventory

    Parent-rated therapy satisfaction is evaluated with the Therapy Attitude Inventory, which includes 10 items, each rated between 1 to 5. Total sum ranges between 10-50, where a higher score indicates more satisfaction with treatment.

    Time frame: Post-treatment (treatment phase 10 weeks)

  2. Parental experiences of the treatment explored through individual qualitative interviews

    Qualitative interviews will explore parent's experiences of participating in the treatment and of using parental strategies, and includes questions about experienced effectiveness, feasibility, satisfaction. Three questions target helpfulness, relevance and usefulness, and are rated 0-10. Total sum ranges between 0-30, with higher scores indicating greater levels of usefulness.

    Time frame: Post-treatment (treatment phase 10 weeks)

  3. Clinician experiences of the treatment explored through individual qualitative interviews

    Qualitative interviews will explore clinicians' experiences of the treatment and includes questions about experienced effectiveness, feasibility, satisfaction.

    Time frame: Post-treatment (treatment phase 10 weeks)

  4. Caregiver: Background information

    A few questions on caregiver and child background.

    Time frame: First weekly assessment (baseline phase week 1)

  5. Parent reported satisfaction with the online video modules

    Caregivers report satisfaction with the videos in each online module through 4 questions rated on a 5 point scale scored 1-5 (total summary score is minimum 4, maximum 20). Higher score indicates greater satisfaction.

    Time frame: Weekly during treatment phase (up to 10 weeks)

  6. Parent-reported experience with the online modules

    Caregivers report in free text their experiences with online modules, e.g., if something was difficult to understand or was missing.

    Time frame: Weekly during treatment phase (up to 10 weeks)

  7. Clinician-rated manual adherence and family alliance

    5 weekly questions to clinicians on manual adherence and experienced alliance with families. Rated on an 11 point scale from 0 to 10 (total weekly summary score is minimum 0, maximum is 50). Higher score indicates greater adherence and alliance.

    Time frame: Weekly during treatment phase (up to 10 weeks)

  8. Parent completion of online modules and treatment sessions

    The number of modules completed are assessed through data from the online platform and completed sessions.

    Time frame: Weekly during treatment phase (up to 10 weeks)

07

Study locations

2 sites
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Oct 1, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07201090
Collaborators
Region Stockholm
Responsible party
Pia Enebrink (Associate professor, Karolinska Institutet) — Principal investigator
First posted
Oct 1, 2025
Start date
Oct 1, 2025 (estimated)
Primary completion
Dec 31, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Oct 1, 2025

Study contacts

Pia Enebrink, PhD
Contact
pia.enebrink@ki.se
+46852487738
Pia Enebrink, PhD
principal investigator · Karolinska Institutet

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion